Cardiac drugs and outcome in COVID-19
Ajay Kumar Mishra, Kamal Kant Sahu, Jennifer Sargent
Abstract
We read with much interest the article “Are certain drugs associated with enhanced mortality in COVID -19” by Goldstein et al your esteemed Journal. Authors have discussed the theoretical basis of angiotensin receptor blockers, statins in worsening outcome of COVID – 19 patients.(1) We believe that this topic is rapidly evolving and requires further evidence and discussion for understanding the multiple factors which contribute to the pathogenesis and outcome. We have the following comments.
Topics & Concepts
Coronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MedicineVirologyOutcome (game theory)Internal medicineMathematicsInfectious disease (medical specialty)OutbreakDiseaseMathematical economicsCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19Cardiac Health and Mental Health